Uncategorised - European Medical Journal

Gene Signature Predicts Chemotherapy Benefit in Early Lung Cancer

A 14-gene test helps identify patients with early-stage non-small-cell lung cancer who benefit from chemotherapy, significantly improving 24-month disease-free survival.

Guselkumab Shows Strong Results in Scalp Psoriasis Study

VISIBLE Cohort B represents a landmark study in psoriasis research, being the only scalp psoriasis trial exclusively including individuals with skin of colour.

Drug-Resistant Epilepsy Predicts Epilepsy Monitoring Unit Success

Short stays in pediatric epilepsy monitoring units (EMUs) achieve diagnostic goals in the majority of cases, with drug-resistant epilepsy emerging as a key predictor of both success and repeat admissions, according to a retrospective analysis of 462 admissions over a 10-year period.

Weaker but Present: Vitamin D Ties to COVID Severity

Vitamin D deficiency remains significantly associated with worse clinical outcomes in patients with COVID-19, even in the post-Omicron era, according to new findings from a large-scale retrospective cohort study.

Remote Exercise Program Enhances Focus in Children with ADHD

Recent studies have shown that exercise interventions can improve ADHD symptoms and enhance executive functions.

ESHRE 2025: PCOS May Be Passed Down Epigenetically

A study presented at ESHRE 2025 reveals epigenetic alterations in embryos from women with PCOS, suggesting a biological basis for inherited risk.

Serotonin Receptor Gene Linked to Sleep Apnoea

The serotonin receptor gene HTR1F was linked to increased risk of sleep apnoea in non-obese adults.

Congress Wrap: EHA 2025

Our wrap-up video captures all the key moments from the European Hematology Association (EHA) Congress 2025, watch now

Can Metformin Reduce Cancer in IBD?

Metformin use linked to significantly lower colorectal cancer risk in patients with inflammatory bowel disease, according to a new population-based cohort study.

MRI Scoring Predicts Recovery in Cardiac Arrest Survivors

MRI-based scoring after cardiac arrest may help predict neurological recovery at discharge in survivors of OHCA.